INVH vs STRO · P/E 42, rev $2.62B vs rev $62.0M
Invitation Homes Inc (INVH) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Invitation Homes Inc (INVH) is a reit - residential company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported INVH revenue for 2024-12-31 was $2.62B. Net income was $455.4M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
INVH currently screens at market cap $19.99B and trailing P/E 41.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the INVH and STRO stock pages for the full models.
Not investment advice.